No Photo Available

Last Update

2016-10-06T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Nabil Dib?

Dr. Nabil Dib

Director of Clinical Cardiovascular Cell Therapy and An Associate Professor of Medicine

University of California , San Diego

Direct Phone: (480) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

University of California , San Diego

9500 Gilman Drive

La Jolla, California 92093

United States

Company Description

The University of California San Diego is a student-centered, research-focused, service-oriented public institution that provides opportunity for all. Recognized as one of the top 15 research universities worldwide and born of a culture of collaboration, ... more

Find other employees at this company (24,554)

Background Information

Employment History

President

Heart Sciences Center

Director, Cardiovascular Research

Mercy Gilbert Medical Center

Director Cardiovascular Research

Dignity Health

Affiliations

Founder and President
International Society for Cardiovascular Translational Research

Scientific Advisory Board Member
Ventrix Inc

Scientific Advisory Board Member
Stemedica Cell Technologies Inc

SCIENTIFIC ADVISORY BOARD Member
Cardiology Online Inc

Board Member
Directors..

Scientific Advisory Board Member
Animal Cell Therapies Inc.

Medical Advisor
Cardiovascular Systems Inc

Founder
Cardiovascular Research Center

Education

Arizona Heart Institute

Tufts University School of Medicine

Degree in Master of Science

Epidemiology

Harvard Medical School

M.D.

M.D.

University of California , San Diego

MSc

Medical Degree

Damascus University School of Medicine

Myocardial Stem Cell

degree in Master of Science

Epidemiology and Research

Harvard School of Public Health

master's degree

epidemiology

Harvard School of Public Health

medical degree

Damascus University

Web References (116 Total References)


ISCTR » ISCTR Governing Board

isctr.org [cached]

Nabil Dib, MD, MSc, FACC

President, USA
...
Dr. Nabil Dib, M.D., MSc, FACC is one of the world's most renowned cardiovascular researchers and doctors. He completed his Interventional Cardiology Fellowship Program at Harvard Medical School, Beth-Israel-Deaconess Medical Center in Boston. Dr. Dib also completed an additional year in Investigational Devices at Harvard Medical School. Additionally, he continued his education at Harvard School of Public Health, where he obtained a degree in Master of Science in Epidemiology and Research, concentrated on a clinical trial designed and effectiveness.
He is an Associate Professor of Medicine and Director of Clinical Cardiovascular Cell Therapy, at University of San Diego, Director of Cardiovascular Stem Cell Consultants and Heart Sciences Center, President and Founder of the International Society for Cardiovascular Translational Research (ISCTR) and Founder and Editor in Chief of the Journal of Cardiovascular Translational Research.
For more than 13 years, Dr. Dib has been conducting research and developing the newest investigational treatments for advanced cardiovascular disease. He is internationally known and respected for his research and work regarding the use of adult stem cells to restore the health of patients with severe heart disease.
Dr Dib is currently the Director of Cardiovascular Research for Mercy Gilbert and Chandler Hospitals in Gilbert, Arizona.


CompanyNews

www.ceocast.com [cached]

Dr. Nabil Dib, an interventional cardiologist at University of California at San Diego's School of Medicine, will serve as a consultant to the company and lead the cellular transplantation team to advance the Myoblast Program clinical efficacy trials.


News | Leonhardt Ventures

www.leonhardtventures.com [cached]

Dr. Warren Sherman of Columbia University and Dr. Nabil Dib of the University of California, San Diego presented data on this approach, which has been used to treat over 300 patients in clinical trials since 2000.

...
A separate study led by Dr. Nabil Dib, sponsored by Advanced Cell Therapy, Inc., showed similar results, and both groups have now moved onto Phase II/III placebo controlled trials currently in the process of enrolling together more than 495 patients. The procedure (16 injections in a cardiac cath lab) takes about 45 minutes.


Nabil Dib, M.D., M.Sc. | Ventrix

ventrixheart.com [cached]

Nabil Dib, M.D., M.Sc.

Director of Cardiovascular Research at Mercy Gilbert & Chandler Regional Medical Centers (Catholic Healthcare West (CHW)). He is also an Associate Professor of Medicine and Director of Clinical Cardiovascular Cell Therapy, University of California San Diego, Director of Cardiovascular and Stem Cell Consultants (CSCC) and Heart Sciences Center, President and Founder of the International Society for Cardiovascular Translational Research (ISCTR) and Founder and Editor in Chief of the Journal of Cardiovascular Translational Research (JCTR).


About Dr. Nabil Dib, Cardiovascular Researcher and Doctor. Investigational Treatments for Advanced Cardiovascular Disease, Adult Stem Cells Research, Severe Heart Disease :: Heart Sciences Center is Based in Gilbert ad Chandler Arizona

www.heartsciencescenter.com [cached]

Dr. Dib Clinical Team

...
About Dr. Nabil Dib
Nabil Dib, M.D., MSc,FACC is one of the world's most renowned cardiovascular researchers and doctors.
View Curriculum Vitae (requires Adobe® Reader®)
For nearly 20 years, Dr. Dib has been conducting research and developing the newest investigational treatments for advanced cardiovascular disease. He is internationally known and respected for his research and work regarding the use of adult stem cells to restore the health of patients with severe heart disease.
Dr. Dib travels the world speaking at Cardiology events, conducting research and clinic trials and working to improve quality of life and survival for patients with cardiovascular disease.
He completed his Interventional Cardiology Fellowship Program at Harvard Medical School, Beth-Israel-Deaconess Medical Center in Boston. Dr. Dib also completed an additional year in Investigational Devices at Harvard Medical School. Additionally, he continued his education at Harvard School of Public Health, where he obtained a degree in Master of Science in Epidemiology and Research, concentrated on a clinical trial designed and effectiveness.
Dr. Dib completed three years of General Cardiology at the University of Wisconsin, Milwaukee Clinical Campus at Sinai Samaritan Medical Center. His residency was in Internal Medicine at Tufts University School of Medicine and his internship at Boston University. Dr. Dib received his Medical Degree from Damascus University School of Medicine in Damascus, Syria.
Currently, he is Director of Cardiovascular Research at Mercy Gilbert & Chandler Regional Medical Centers, members of Catholic Healthcare West (CHW). He is also an Associate Professor of Medicine and Director of Clinical Cardiovascular Cell Therapy, University of California San Diego, Director of Heart Sciences Center, President and Founder of the International Society for Cardiovascular Translational Research and Editor in Chief of the Journal of Cardiovascular Translational Research.
As Director, Cardiovascular Research at Mercy Gilbert & Chandler Regional Medical Centers, Dr. Dib has led the charge for the healthcare industry to find innovative ways to utilize adult non-embryonic stem cells that may have the potential to restore the health of patients who have no other available treatments.
Dr. Dib is internationally known for his research and work with stem cell therapy. He did the first worldwide experiment to demonstrate the feasibility of stem cell transplantation using 3-D catheter guidance in February 2000 and a few months later he implanted the first patient with stem cell therapy. In 2004, he obtained the first FDA approval in the United States for stem cell transplantation for patients with heart failure and heart attack using the 3-D catheter guidance technology, a minimally invasive procedure.
Dr. Dib also authored a book on the topic titled, Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications.
Prior to joining Catholic Healthcare West, Dr. Dib formed Cardiovascular and Stem Cell Consultants (CSCC), a cardiology practice that provides the highest quality healthcare to patients with cardiovascular disease. CSCC also provides patients access to the newest investigational treatments for advanced cardiovascular disease such as Adult Stem Cells, Gene Therapy, and New Devices, a very important program for personalized medicine.
Additional experience includes seven years at the Arizona Heart Institute in Phoenix, Ariz., where Dr. Dib was Director of Interventional Cardiovascular Research and Director of the Interventional Fellowship Program. During his tenure with the Arizona Heart Institute, Dr. Dib was named America's Top Doctors for Interventional Cardiology in 2003.
Throughout his career, Dr. Dib has served on several advisory boards and steering committees including: Cordis/Johnson & Johnson, Schering/Berlex, Volcano Corp., POSSIS Medical Inc., and Cardiovascular System Inc. In 2007, he was named Proctor, 3-D Mapping and stem cell transplantation for Biologics Delivery Systems/Cordis Corporation, a Johnson & Johnson Company.
He has also been involved with numerous professional affiliations such as: the American Heart Association, American College of Cardiology, American College of Physicians, International Society of Endovascular Intervention and the Massachusetts Medical Society. In addition, Dr. Dib helped write the board exam for the American College of Cardiology and is a reviewer for several medical journals and publications.
His research interests include Stem Cell Therapy for Myocardial Regeneration and Methods of Delivery, Genomics, Personalized Medicine, New Investigational Devices in Cardiology.
In addition, Dr. Dib has done extensive work in the following areas: Stent Deployment, Doppler FloWire, Pressurewire, Intravascular Ultrasound, Valvuloplasty, Rotational Atherectomy, Directional Atherectomy, Beta-Radiation, Novoste, Possis Angiojet, PercuSurge GuardWire System, Angioseal, Perclose and Vasoseal.
To learn more about Dr. Dib's accomplishments and recent media coverage, visit our Media Center.
Women's cholesterol levels tend to rise as they age.
Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair by Dr. Dib

Similar Profiles

Other People with this Name

Other people with the name Dib

Carolyn Dib
MedAmerica , Inc.

Terri Dib
AtlantiCare Foundation Inc

Caroline Dib
Club Quarters

Mario Dib
American University of Beirut

Jessica Dib
NEXtCARE

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory